Actuate Therapeutics ACTU
NASDAQ ACTU
$0.71 +0.02 (+3.47%)
As of: Sep 30, 2026 · 10:23 AM EDT

Actuate Therapeutics (ACTU) EBIT (2023 - 2026)

Updated

Actuate Therapeutics' EBIT came in at -$4.91 million for Q2 2026, compared with -$5.97 million a year earlier.

Analysis

Actuate Therapeutics (ACTU) EBIT (2023 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Actuate Therapeutics reported EBIT of -$21.04 million; for FY2025, it was -$22.5 million.

  • Going back by year, EBIT was -$25.16 million in FY2024 and -$24.97 million in FY2023.
  • The five-year range for quarterly EBIT is -$7.77 million (Q1 2024) to -$4.69 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 7.14 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 6.43 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -584.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 4.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 3.16 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 3.51 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -10.39 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 4.27 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 1.25 Bn
10 Actuate Therapeutics 17.77 Mn 17.77 Mn - -4.91 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -4.91 Mn
Dec 31, 2025 -4.69 Mn
Sep 30, 2025 -5.47 Mn
Jun 30, 2025 -5.97 Mn
Mar 31, 2025 -6.37 Mn
Dec 31, 2024 -6.56 Mn
Sep 30, 2024 -5.39 Mn
Jun 30, 2024 -5.44 Mn
Mar 31, 2024 -7.77 Mn
Dec 31, 2023 -7.62 Mn
Sep 30, 2023 -6.48 Mn
Jun 30, 2023 -5.58 Mn
API Access

Actuate Therapeutics EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit&ticker=ACTU&period=max&api_key=YOUR_API_KEY